Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: MarketLine (a Datamonitor Company)
$175.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Daiichi Sankyo Co Ltd and Ranbaxy Laboratories Ltd Launch Hybrid Business in Brazil- Newswire18


Tuesday, 16 Apr 2013 08:00pm EDT 

Newswire18 reported that Ranbaxy Laboratories Ltd announced that it has launched a hybrid business with Daiichi Sankyo Co Ltd in Brazil to expand business of both companies. Ranbaxy Laboratories will support Daiichi Sankyo's Brazil-based subsidiary, Daiichi Sankyo Brasil Farmaceutica Ltda, to enter the branded generics market in addition to its established business of providing innovative products.